Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
47.45 USD | +0.83% | -5.33% | -21.14% |
Kurzporträt
Mitarbeiterzahl: 1 800
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Novel Cell Therapies
100,0
%
| 117 | 100,0 % | 285 | 100,0 % | +143.70% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
94,7
%
| 117 | 99,7 % | 270 | 94,7 % | +131.47% |
Europe
5,3
%
| 0 | 0,1 % | 15 | 5,3 % | +19’993.33% |
China
0,1
%
| 0 | 0,3 % | 0 | 0,1 % | -45.43% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 01.07.19 |
Lori Macomber
DFI | Director of Finance/CFO | 53 | 01.09.19 |
Tracy Luo
CTO | Chief Tech/Sci/R&D Officer | - | 01.05.18 |
Liz Gosen
CTO | Chief Tech/Sci/R&D Officer | - | 01.05.19 |
Guowei Fang
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.22 |
Mythili Koneru
CTO | Chief Tech/Sci/R&D Officer | 46 | 11.04.23 |
- | - | ||
Jessie Yeung
IRC | Investor Relations Contact | - | 01.01.19 |
Elaine Qian
HRO | Human Resources Officer | - | 01.11.19 |
Yuhong Qiu
LAW | General Counsel | - | 01.05.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 51 | 01.07.19 |
Corazon Sanders
BRD | Director/Board Member | 67 | 01.05.20 |
Li Zhu
BRD | Director/Board Member | 74 | 23.11.20 |
Patrick J. Casey
BRD | Director/Board Member | 68 | 03.12.20 |
Fang Liang Zhang
CEO | Chief Executive Officer | 59 | 27.05.15 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 02.08.22 |
Ye Wang
BRD | Director/Board Member | 55 | 01.05.15 |
Wai Man Yau
BRD | Director/Board Member | 48 | 01.05.20 |
Xiao Hui Ji
BRD | Director/Board Member | 62 | 01.05.20 |
Li Mao
BRD | Director/Board Member | 67 | 02.08.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 363 822 069 | 360 183 848 ( 99,00 %) | 0 | 99,00 % |
Unternehmenskontakt
Sektor
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-21.14% | 8.63 Mrd. | |
-0.49% | 105 Mrd. | |
+3.31% | 97.5 Mrd. | |
+2.18% | 22.19 Mrd. | |
-16.16% | 21.33 Mrd. | |
-7.29% | 18.68 Mrd. | |
-41.41% | 16.6 Mrd. | |
-22.87% | 14.52 Mrd. | |
+6.32% | 14.09 Mrd. | |
+21.46% | 10.99 Mrd. |
- Börse
- Aktien
- A2P5AH Aktie
- Unternehmen Legend Biotech Corporation